Test of the DNMT1o imprinted maintenance methylation model reveals progressive methylation loss between eight-cell and blastocyst stages
Development · 2026-11-01 · 153 (21)
DOI: 10.1242/dev.206104 ↗At a glance
Journal article in Development, published online on 2026-11-09. Written by Calandra N Matoushaya and 4 co-authors. Institution: Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. Major MEDLINE topics: DNA Methylation, Genomic Imprinting, Blastocyst, DNA (Cytosine-5-)-Methyltransferases. 55 references. The full text is freely available (open access, CC BY 4.0). Funded by: Eunice Kennedy Shriver National Institute of Child Health and Human Development, Magee-Womens Research Institute, Tsinghua University.
Abstract (original language)
DNMT1o, the maternal oocyte-derived isoform of DNA methyltransferase 1, is a key protein in maintaining imprinted methylation. A model was proposed in 2001, and refined in 2008, where DNMT1o acts to maintain imprinted methylation exclusively at the eight-cell stage during preimplantation development. Nearly 20 years later, this is the first comprehensive analysis testing the maternal DNMT1o imprinted maintenance methylation model. We analyzed Snrpn and H19 imprinted methylation in individual control and maternal Dnmt1o-deficient mouse embryos across five preimplantation stages. Our findings challenged assumptions that DNMT1o acted solely at the eight-cell stage to produce ∼50% methylation loss in all embryos. Compared to controls, maternal Dnmt1o-deficient embryos experienced: (1) progressive Snrpn and H19 imprinted methylation loss between the eight-cell to blastocyst stages, with inter-embryo variability extending beyond the predicted 50% loss; cleavage-stage embryos exhibited similar methylation levels; (2) some embryos maintained maternal Snrpn and paternal H19 methylation, bypassing imprinted methylation loss; and (3) at the DNA strand level, Snrpn and H19 methylation loss was sporadic rather than complete. These findings point to potential compensation mechanisms during early preimplantation development.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Obstetrics, Gynecology and Reproductive Sciences, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.
- Magee-Womens Research Institute, Pittsburgh, PA 15213, USA.
- School of Medicine, Tsinghua Medicine, Tsinghua University, Beijing 100084, China.
ORCID profiles: Benjamin Shaffer, Qidan Hu, Mellissa R W Mann
Funding
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
- Magee-Womens Research Institute
- Tsinghua University
- NIH HHS
- University of Pittsburgh
- National Institutes of Health
Cite
APA
Matoushaya, C. N., Pena-Bello, C. A., Shaffer, B., Hu, Q., & Mann, M. R. W. (2026). Test of the DNMT1o imprinted maintenance methylation model reveals progressive methylation loss between eight-cell and blastocyst stages. Development, 153(21). https://doi.org/10.1242/dev.206104
Vancouver
Matoushaya CN, Pena-Bello CA, Shaffer B, Hu Q, Mann MRW. Test of the DNMT1o imprinted maintenance methylation model reveals progressive methylation loss between eight-cell and blastocyst stages. Development. 2026;153(21). doi:10.1242/dev.206104
BibTeX
@article{Matoushaya2026,
author = {Matoushaya, Calandra N and Pena-Bello, Camilo A and Shaffer, Benjamin and Hu, Qidan and Mann, Mellissa R W},
title = {Test of the DNMT1o imprinted maintenance methylation model reveals progressive methylation loss between eight-cell and blastocyst stages},
journal = {Development},
year = {2026},
volume = {153},
number = {21},
doi = {10.1242/dev.206104}
}
EUVIMED